1. Home
  2. IVA vs AMTB Comparison

IVA vs AMTB Comparison

Compare IVA & AMTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • AMTB
  • Stock Information
  • Founded
  • IVA 2011
  • AMTB 1979
  • Country
  • IVA France
  • AMTB United States
  • Employees
  • IVA N/A
  • AMTB N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • AMTB Major Banks
  • Sector
  • IVA Health Care
  • AMTB Finance
  • Exchange
  • IVA Nasdaq
  • AMTB Nasdaq
  • Market Cap
  • IVA 769.0M
  • AMTB 726.3M
  • IPO Year
  • IVA 2020
  • AMTB N/A
  • Fundamental
  • Price
  • IVA $4.21
  • AMTB $17.06
  • Analyst Decision
  • IVA Strong Buy
  • AMTB Buy
  • Analyst Count
  • IVA 8
  • AMTB 4
  • Target Price
  • IVA $16.13
  • AMTB $21.75
  • AVG Volume (30 Days)
  • IVA 492.4K
  • AMTB 389.8K
  • Earning Date
  • IVA 09-29-2025
  • AMTB 10-28-2025
  • Dividend Yield
  • IVA N/A
  • AMTB 2.11%
  • EPS Growth
  • IVA N/A
  • AMTB N/A
  • EPS
  • IVA N/A
  • AMTB 1.59
  • Revenue
  • IVA $19,929,536.00
  • AMTB $388,504,000.00
  • Revenue This Year
  • IVA N/A
  • AMTB $61.98
  • Revenue Next Year
  • IVA N/A
  • AMTB $4.00
  • P/E Ratio
  • IVA N/A
  • AMTB $10.72
  • Revenue Growth
  • IVA N/A
  • AMTB 51.98
  • 52 Week Low
  • IVA $2.11
  • AMTB $15.62
  • 52 Week High
  • IVA $7.98
  • AMTB $26.24
  • Technical
  • Relative Strength Index (RSI)
  • IVA 44.77
  • AMTB 41.33
  • Support Level
  • IVA $3.55
  • AMTB $16.81
  • Resistance Level
  • IVA $4.10
  • AMTB $17.74
  • Average True Range (ATR)
  • IVA 0.28
  • AMTB 0.49
  • MACD
  • IVA 0.00
  • AMTB 0.08
  • Stochastic Oscillator
  • IVA 71.26
  • AMTB 29.57

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About AMTB Amerant Bancorp Inc.

Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.

Share on Social Networks: